ASSET PURCHASE AGREEMENT by and among ERYTECH PHARMA, S.A., ERYTECH PHARMA, INC., CATALENT PRINCETON, LLC and CATALENT PHARMA SOLUTIONS, INC. (solely for purposes of Section 6.17) dated as of April 22, 2022